OCULAR MYASTHENIA GRAVIS
Clinical trials for OCULAR MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new OCULAR MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for OCULAR MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to ease droopy eyelids and double vision
Disease control Recruiting nowThis study tests an investigational drug called rozanolixizumab against a placebo in 120 adults with ocular myasthenia gravis, a condition causing eye muscle weakness like droopy eyelids or double vision. Participants receive the drug or placebo by injection, and researchers meas…
Matched conditions: OCULAR MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Which drug best prevents eye muscle weakness from spreading? new study aims to find out
Disease control Recruiting nowThis study looks at 200 adults with new-onset ocular myasthenia gravis, a condition that causes droopy eyelids and double vision. Researchers will compare different treatments, including steroids and immunosuppressants like azathioprine and tacrolimus, to see which works best and…
Matched conditions: OCULAR MYASTHENIA GRAVIS
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New strategy aims to stop eye muscle disease from spreading
Disease control Recruiting nowThis study tests whether starting steroids right away, and adding rituximab if symptoms return, can prevent eye muscle weakness from spreading to other muscles in people with ocular myasthenia gravis. About 128 adults with recent diagnosis will be followed for 2 years. The goal i…
Matched conditions: OCULAR MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC